Browse > Article
http://dx.doi.org/10.5012/bkcs.2003.24.4.460

Synthesis of Ketoconazole Derivatives  

Ryu, Jae-Chun (Department of Chemistry, Kunsan National University)
Lee, Kwang-Jae (Department of Chemistry, Kunsan National University)
Lee, Sang-Hee (Department of Chemistry, Kunsan National University)
Publication Information
Abstract
For the drug master file (DMF) of ketoconazole, four impurities (1-4) contained in ketoconazole were synthesized. During the synthesis of 2, a new synthetic method of 1,4-dihydropyrazine was established. To oxidize the aminoalcohol (2j) to the aminal (2j-1), the standard Swern oxidation condition was modified to mask the nucleophilicity of the amino group temporarily using one equivalent of acetic acid. Derivative 3 was synthesized via regioselective bromination at the 2 position of the 4-aminophenol derivative (3a) using $Br_2$ in the presence of p-TsOH. The etherification of aryl bromide with the phenol derivative (1f) was accomplished by a modification of the general Cu-mediated reaction condition using excess 1f itself as a solvent at elevated temperature (190 ℃).
Keywords
Drug master file (DMF); Ketoconazole; Impurities; 1,4-Dihydropyrazine;
Citations & Related Records

Times Cited By Web Of Science : 0  (Related Records In Web of Science)
Times Cited By SCOPUS : 2
연도 인용수 순위
1 Marcoux, J. F.; Doye, S.; Buchwald, S. J. Am. Chem. Soc. 1997,119, 10539.   DOI   ScienceOn
2 Bendix, D. Polymer Degradation and Stability 1998, 59, 129.   DOI   ScienceOn
3 Vanden Bossche, H.; Willemsens, G.; Cools, W.; Cornelissen, F.;Lauwers, W.; Van Cutsem, J. M. Antimicrob. Agents Chemother.1980, 17, 922.   DOI   ScienceOn
4 Ishii, Y.; Chatani, N.; Kakiuchi, F.; Murai, S. Tetrahedron Letters1997, 38, 7565.   DOI   ScienceOn
5 Omura, K.; Swern, D. Tetrahedron 1978, 34, 1651.   DOI   ScienceOn
6 Sawyer, J. S.; Schmittling, E. A.; Palkowitz, J. A.; Smith, W. J. J.Org. Chem. 1998, 63, 6338.   DOI   ScienceOn
7 Camps, P.; Farres, X. Tetrahedron; Asymmetry 1995, 6, 1283.   DOI   ScienceOn
8 Kraemer, F. B.; Pont, A. Am. J. Med. 1986, 80, 616.   DOI   ScienceOn
9 Keirs, D.; Overton, K. J. Chem. Soc., Chem. Commun. 1987,1660.
10 The Rules Governing Medicinal Products in the European Union,Quality Guidelines European Drug Master File Procedure forActive Substances; 1998; Vol. 3A.
11 Heel, R. C.; Brogden, R. N.; Carmine, A.; Morley, P. A.; Speight, T. M.; Avery, G. S. Drugs 1982, 23, 1.   DOI
12 Shepherd, F. A.; Hoffert, B.; Evans, W. K.; Emery, G.;Trachtenberg, J. Arch. Intern. Med. 1985, 145, 863.   DOI   ScienceOn
13 Heeres, J.; Backx, L. J.; Mostmans, J. H.; Van Cutsem, J. J. Med.Chem. 1979, 22, 1003.   DOI
14 Ballard, S. A.; Lodola, A.; Tarbit, M. H. Biochem. Pharmacol.1988, 37, 4643.   DOI   ScienceOn
15 Aranyos, A.; Oid, D. W.; Kiyomori, A.; Wolfe, J. P.; Sadighi, J. P.;Buchwald, S. L. J. Am. Chem. Soc. 1999, 121, 4369.   DOI   ScienceOn
16 Kallinayer, H. J.; Petesch, N. Pharm. Acta Helv. 1991, 66, 178.